Instrument Inactif

Communiqués ZymoGenetics, Inc.

Actions

US98985T1097

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

29/09/10	ZYMOGENETICS : Reports Favorable Survival Data from IL-21 Phase 2a Clinical Trial in Melanoma	BU
15/09/10	ZYMOGENETICS : Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of ZymoGenetics, Inc.	BU
13/09/10	ZYMOGENETICS : The Law Office of Abe Shainberg Announces an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ZymoGenetics, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Co. - ZGEN	BU
08/09/10	ZYMOGENETICS : Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of ZymoGenetics, Inc. – ZGEN	BU
08/09/10	ZYMOGENETICS : The Law Offices of Vincent Wong Announces an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ZymoGenetics, Inc. - ZGEN	BU
08/09/10	ZYMOGENETICS : The Briscoe Law Firm Investigates ZymoGenetics Inc.'s Board Concerning the Acquisition of ZymoGenetics by Bristol-Myers Squibb Company	BU
08/09/10	ZYMOGENETICS : Ryan & Maniskas, LLP Announces Investigation of ZymoGenetics, Inc.	BU
08/09/10	ZYMOGENETICS : The Law Office of Robbins Umeda LLP Announces an Investigation of the Tender Offer by Bristol-Myers Squibb Company to Acquire ZymoGenetics, Inc.	BU
08/09/10	ZYMOGENETICS : Law Office of Jonathan M. Stein, P.L. Investigates Possible Breach of Fiduciary Duty by the Board of ZymoGenetics, Inc.	BU
08/09/10	ZYMOGENETICS : Levi & Korsinsky, LLP Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of ZymoGenetics, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Co. - ZGEN	BU
08/09/10	ZYMOGENETICS : Kendall Law Group Investigates ZymoGenetics, Inc. Acquisition for Shareholders	BU
25/08/10	ZYMOGENETICS : Announces Completion of Enrollment in Phase 2b Clinical Trial with PEG-Interferon lambda in Hepatitis C	BU
04/08/10	ZYMOGENETICS : to Webcast Presentation at the Canaccord Annual Growth Conference	BU
03/08/10	ZYMOGENETICS : Reports Second Quarter 2010 Financial Results	BU
12/07/10	ZYMOGENETICS : to Host Conference Call and Webcast on August 3, 2010 to Discuss Second Quarter 2010 Financial Results	BU
18/06/10	ZYMOGENETICS : Lars Fruergaard Jørgensen Joins the ZymoGenetics Board of Directors	BU
15/06/10	ZYMOGENETICS : to Webcast Presentation at the Piper Jaffray Europe Conference	BU
05/06/10	ZYMOGENETICS : Reports Positive IL-21 Phase 2 Results in Metastatic Melanoma	BU
02/06/10	ZYMOGENETICS : Initiates PEG-Interferon lambda Phase 2b Clinical Trial in Hepatitis C in Collaboration with Bristol-Myers Squibb	BU
21/05/10	ZYMOGENETICS : Announces Upcoming Presentation of Positive IL-21 Phase 2 Results in Metastatic Melanoma at ASCO Meeting	BU
30/11/-1	Zymogenetics : ZymoGenetics, Inc. Reports Initial rhThrombin Results	BU
30/11/-1	Zymogenetics : ZymoGenetics to Review Development Programs at Analyst & Investor Briefing	BU
30/11/-1	Zymogenetics : Webcast Alert: ZymoGenetics, Inc. Announces Its Zymogenetics Q3 2006 Financial Results Conference Call Webcast	BU
30/11/-1	ZYMOGENETICS : Stock Alerts on Industry Leaders: INTC, INSM, GD, ZGEN, YRCW, LEA; Issued by Beacon Equity	PR